Eli Lilly LLY Payment for (Proceeds from) Other Investing Activity
Payment for (Proceeds from) Other Investing Activity at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromOtherInvestingActivities.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's payment for (proceeds from) other investing activity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eli Lilly's payment for (proceeds from) other investing activity?
- Eli Lilly (LLY) reported payment for (proceeds from) other investing activity of $31M in Q1 2026.
- How has Eli Lilly's payment for (proceeds from) other investing activity changed year-over-year?
- Eli Lilly's payment for (proceeds from) other investing activity increased by 127.9% year-over-year, from -$111M to $31M.
- What is the long-term trend for Eli Lilly's payment for (proceeds from) other investing activity?
- Over 2 years (2021 to 2025), Eli Lilly's payment for (proceeds from) other investing activity has grown at a -92.8% compound annual growth rate (CAGR), from $191.7M to -$1M.
- What does payment for (proceeds from) other investing activity mean?
- Net cash flows resulting from investing activities that do not fall under standard categories like securities or loans. This may include investments in joint ventures, real estate, or other non-financial assets. It serves as a catch-all for miscellaneous capital deployment or divestment activities.